期刊文献+

抗肿瘤药物来那度胺的合成方法 被引量:1

Synthetic method of anticancer drugs lenalidomide
下载PDF
导出
摘要 2-甲基-3-硝基苯甲酸甲酯(1)与卤化剂反应,制得2-卤甲基-3-硝基苯甲酸甲酯(2)。L-谷氨酰胺(3)经酯化反应制得谷氨酰胺甲酯(4),在Boc试剂、偶联剂和催化剂的作用下,进行分子内关环,制得Boc保护的3-氨基哌啶-2,6-二酮(7),与2-卤甲基-3-硝基苯甲酸甲酯(2)在弱碱的条件下合环,经硝基还原反应,得到来那度胺(9)。本方法反应条件较温和,反应步骤简单易行,降低了生产成本,并且提高了产率,总收率约为40%。 2-Halomethyl-3-nitrobenzoate (2) was obtained from 2-methyl-3-nitrobenzoate ( 1 ) via haloge- nation reactions. Glutamine methyl ester (4) was obtained from L-glutamine (3) via esterification,3-ami- no-piperidine-2,6-dione (7) was obtained from intramolecular cyclization under Boc reagent,condensing agent and catalyst. Compound (2) and (7) cyclization under weak base condensation, followed by nitro- reduction to give lenalidomide (9). This synthetic method can shorten reaction steps, reduce production costs and improve yield to about 40% in a mild reaction condition.
出处 《应用化工》 CAS CSCD 2013年第3期572-574,577,共4页 Applied Chemical Industry
基金 2012年甘肃省创新团队建设计划(1207TTCA009) 甘肃省精细化工重点实验室建设计划(甘科计[2012]19号)
关键词 来那度胺 抗肿瘤药物 骨髓增生异常综合症 合成 lenalidomide antitumor agent myelodysplastic syndrome(MDS) synthesis
  • 相关文献

参考文献18

  • 1宋丽洁,封宇飞,傅得兴,胡欣,王唯红.新型免疫调节药来那度胺的药理及临床研究进展[J].中国新药杂志,2006,15(21):1889-1892. 被引量:14
  • 2Kale V, List A F. Immunomodulatory drags ( IMiDsTM ) : a new treatment option for myelodysplastic syndromes [ J ]. Curt Pharm Biotechno1,2006,7 ( 5 ) :339-342.
  • 3Abe M, Iyama Ak T, Umeazwa Y,et al. Synthesis and bio- logical activity of sulphost in analogues, novel dipeptidyl peptidase IV inhibitors [ J]. Bioorg Med Chem,2005,13 ( 3 ) :785-797.
  • 4方峰,许煦,冀亚飞.来那度胺的合成[J].中国医药工业杂志,2008,39(12):888-891. 被引量:9
  • 5Zhu X X, Giordano T, Yu Q S, et al. Thiothalidomides : no- vel isosterie analogues of thalidomide with enhanced TNF- c inhibitory activity [ J ]. J Med Chem, 2003,46 ( 24 ) : 5222-5229.
  • 6Fox D J, Reckless J, Warren S G, et al. Design, synthesis and preliminary pharmacological evaluation of N-acyl-3- aminoglutarimides as broad-spectrum chemokine inhibitors in vitro and anti-inflammatory agents in vivo [ J ]. J Med Chem, 2002,45 ( 2 ) : 360 -370.
  • 7吴晗,唐玫,张爱英,刘增路,毛振民.来那度胺的合成[J].中国医药工业杂志,2010,41(3):164-166. 被引量:9
  • 8List A F. Lenalidomide the phoenix rises [ J ]. N Engl J Med,2007,357(21 ) :2183-2186.
  • 9Sorbera L A, Castafier J, Bay6s M. Treatment of multiple myeloma treatment of melanoma treatment of myelodys- plastic syndrome angiogenesis inhibitor TNF-ct production inhibitor [ J ]. Drugs Future, 2003,28 ( 5 ) :425-431.
  • 10Muller G W, Chen R, Saindane M T, et al. Processes for the preparation of substituted 2-( 2, 6-dioxopiperidin-3- yl ) - 1 -oxoisoindolines : WO, 2006028964 [ P ]. 2006-03- 1 6.

二级参考文献41

  • 1宋丽洁,封宇飞,傅得兴,胡欣,王唯红.新型免疫调节药来那度胺的药理及临床研究进展[J].中国新药杂志,2006,15(21):1889-1892. 被引量:14
  • 2List AF. Lenalidomide-The phoenix rises [J]. N Engl J ivied, 2007, 357(21): 2183-2186.
  • 3Sorbera LA, Castafier J, Bayes M. CC-5013 [J]. Drugs Future, 2003, 28 (5) : 425-431.
  • 4Muller GW, Chen R, Huang SY, et al. Amino-substituted thalidomide analogs: potent inhibitors of TNF-α production [J]. Bioorg Med Chem Lett, 1999, 9 (11) : 1625-1630.
  • 5Muller GW, Chen R, Saindane MT, et al. Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1- oxoisoindolines: WO, 2006028964 [P]. 2006-03-16. (CA 2006, 144: 292576)
  • 6Soderberg BC, Shriver JA, Wallace JM, et al. Synthesis of indoles by palladium-catalyzed reductive N-heteroannulation of 2-nitrostyrenes: methyl indole-4-carboxylate [J]. Org Synth, 2003, 80: 75-84.
  • 7Abe M, Akiyama T, Umezawa Y, et al. Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase Ⅳ inhibitors [J]. Bioorg Med Chem, 2005, 13 (3) : 785-797.
  • 8Muller GW, Stirling DI, Chen RSC, et al. Substituted 2- (2,6-dioxopiperidin-3-yl)phthalimides and -1 -oxoisoindolines and method of reducing TNF-α levels: WO, 9803502 [P]. 1998-01-29. (CA 1998, 128: 140615)
  • 9Kale V, List AF. Immunomodulatory drugs (IMiDs^TM) : a new treatment option for myelodysplastic syndromes [J]. Curr Pharm Biotechnol, 2006, 7 (5) : 339-342.
  • 10Raghavendracharyulu PV, Veerender M, Amarendhar M. An improved process for the preparation of lenalidomide: IN, 2006CH00047 [P]. (CA2008, 149: 402200).

共引文献22

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部